Document ID: chunk:federal_register_of_legislation:F2025C00183:clause:1_73333
Version: federal_register_of_legislation:F2025C00183
Segment Type: clause
Provision Reference: sch 1 cl 73333
Character Range: 290717–292372

73333              Detection of germline mutations of the von Hippel‑Lindau (VHL) gene:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 600.00
                   (a) in a patient who has a clinical diagnosis of VHL syndrome and:
                   (i) a family history of VHL syndrome and one of the following:
                   (A) haemangioblastoma (retinal or central nervous system);
                   (B) phaeochromocytoma;
                   (C) renal cell carcinoma; or
                   (ii) 2 or more haemangioblastomas; or
                   (iii) one haemangioblastoma and a tumour or a cyst of:
                   (A) the adrenal gland; or
                   (B) the kidney; or
                   (C) the pancreas; or
                   (D) the epididymis; or
                   (E) a broad ligament (other than epididymal and single renal cysts, which are common in the general population); or
                   (b) in a patient presenting with one or more of the following clinical features suggestive of VHL syndrome:
                   (i) haemangiblastomas of the brain, spinal cord, or retina;
                   (ii) phaeochromocytoma;
                   (iii) functional extra‑adrenal paraganglioma